Skip to main content
Clinical Trials/NCT04160169
NCT04160169
Completed
Not Applicable

Counseling on Injectable Contraception and HIV Risk: Evaluation of a Pilot Intervention in Tanzania

University of North Carolina, Chapel Hill10 sites in 1 country10 target enrollmentSeptember 1, 2018
ConditionsContraception

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Contraception
Sponsor
University of North Carolina, Chapel Hill
Enrollment
10
Locations
10
Primary Endpoint
Percent of clients obtaining an injectable during their family planning appointment
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

The main objective of the evaluation was to assess the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and behavior during a three month pilot intervention in ten healthcare facilities in Tanzania.

Detailed Description

The evaluation assessed the effect of providing injectable and HIV risk counseling messages on contraceptive knowledge and uptake during a three month pilot intervention. The intervention was conducted September-November 2018 in ten healthcare facilities located in the Iringa and Njombe regions of Tanzania. Data collection for the evaluation occurred November-December 2018 and included 471 client exit interviews, 26 healthcare provider interviews, and the extraction of monthly aggregate service statistics for 12 months prior to the intervention and three months of the intervention. Univariate and bivariate analyses were used to assess quantitative interview data. Thematic qualitative assessment was used to assess qualitative interview data from healthcare providers. Interrupted time series analysis was used to assess changes in the trend of monthly contraceptive uptake.

Registry
clinicaltrials.gov
Start Date
September 1, 2018
End Date
November 30, 2018
Last Updated
6 years ago
Study Type
Observational
Sex
Female

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Expressed interest in injectable use
  • HIV-negative or unknown HIV status

Exclusion Criteria

  • Positive HIV status known to healthcare provider

Outcomes

Primary Outcomes

Percent of clients obtaining an injectable during their family planning appointment

Time Frame: After implementation of counseling messages, up to 13 weeks

Injectable uptake of interviewed clients

Monthly total number of family planning clients by method obtained

Time Frame: September 2017 through November 2018

Contraceptive uptake during pilot intervention

Number of clients obtaining an injectable during their family planning appointment

Time Frame: After implementation of counseling messages, up to 13 weeks

Injectable uptake of interviewed clients

Secondary Outcomes

  • Number of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall(After implementation of counseling messages, up to 13 weeks)
  • Percent of correct hormonal contraception and HIV risk counseling messages mentioned during spontaneous recall(After implementation of counseling messages, up to 13 weeks)
  • Percent of correct True/False statements on hormonal contraception and HIV (11 total)(After implementation of counseling messages, up to 13 weeks)
  • Percent of interviewed clients reporting an intention to use condoms as a dual method(After implementation of counseling messages, up to 13 weeks)
  • Number of correct True/False statements on hormonal contraception and HIV (11 total)(After implementation of counseling messages, up to 13 weeks)
  • Number of interviewed clients reporting an intention to use condoms as a dual method(After implementation of counseling messages, up to 13 weeks)

Study Sites (10)

Loading locations...

Similar Trials